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Outline
Outline
• Historical spaceflight medical kits/systems
• Historical occurrence of medical conditions
• Upcoming missions and medical challenges
• Medical risk and spaceflight events
• Medical system and technology integration
Objectives
• Describe the key principles of extreme environmental medicine
• Identify the challenges with telemedicine and remote medical support
• Analyze the steps necessary to increase clinical autonomy
• Outline how using systems engineering principles can improve medical 
system design
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Project Mercury
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Principles of Clinical Medicine for Spaceflight
Eds. Barratt, Pool, 2008
FIGURE 4.1. Mercury medical kits containing items such as antibiot-
ics, decongestants, stimu lants, electrode paste, and medications to 
treat nausea and diarrhea. (Photo courtesy of ASA) 
FIGURE 4.2. Mercury medical kit containing items such as saLine 
solution, bandages, stimulants, and decongestants (Photo courtesy 
of ASA) 
Gemini and Apollo
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Principles of Clinical Medicine for Spaceflight
Eds. Barratt, Pool, 2008
TABU1 4.1. Contents of the Gemini VII medical kit ( IO]. 
Medicalion Indication Dose Amounl 
D-Amphetamine sulfate 
Aspirin-phenacetin-
caffeine 
Cycliz.inc HCI 
Diphenoxybte HCI 
Mepcridine HCI 
Methyl cellulose solution 
Parenteral cycliz inc 
Parenteral mepcridine HO 
Pseudoephedrine HCI 
Tctrncycline HCI 
Triprolid ine HCI 
Stimulant 
P:un 
Motion sickness 
Dianhca 
P:un 
Eye lubricant 
Motion sickness 
P:un 
Decongestant 
Antibiotic 
Dcoongesl.:rnt 
5-mg 1ablets 
Tab lets 
50-mg 1ablets 
2.5-mg 1ablcts 
100-mg 1ablcts 
15-ml bottle 
45mg (0.9-ml 
injector) 
90mg (0.9-ml 
injector) 
60-mg lllblets 
250-mg ooated 
tableLli 
2.5-mg tab lets 
8 
16 
8 
16 
4 
I 
2 
16 
16 
16 
F1cURE 4.3. Apollo medical kit containing items such as ski n cream. 
antibiotic ointment, nasal spray. band-aids. and stimu lants (Photo 
councsy of ASA) 
F1cURE 4.4. Apollo Command Module medical kit (Photo counesy 
of NASA) 
FIGURE 4.5. Apollo clinical physiological monitoring kit and emer-
gency medical kit (Photo counesy of ASA) 
- - - ~-UI 
FIGURE 4.6. Apollo emergency medical kit (Photo counesy of ASA) 
Space Shuttle
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Principles of Clinical Medicine for Spaceflight
Eds. Barratt, Pool, 2008
FIGURE 4.7. Shuttle Orbiter Medical System. Following redesign in 
2000, components include Saline Supply Bag, EENT Subpack, IV 
Administration Subpack, Trauma Subpack, Sharps Container, Drug 
Subpack, and Airway Subpack (Photo courtesy of NASA) 
Health and Medical on ISS
7
Principles of Clinical Medicine for Spaceflight
Eds. Barratt, Pool, 2008
CHeCS 
I I 
CMS EHS HMS 
F 1GURE 4.8. ISS Health Maintenance System. Components include 
(from left) defibrillator, Advanced Life Support Pack, Respiratory 
Support Pack, and Crew Medical Restraint System (Photo cou1tesy 
of NASA). 
Do we need medicine in spaceflight?
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Antonsen E, Bayuse T, Blue RS, Daniels V, Hailey M, Hussey S, et al. The Risk of Adverse Health 
Outcomes and Decrements in Performance due to In-Flight Medical Conditions. National Aeronautics 
and Space Administration 2017; TR: NASA/TR-2017-0004604
Medical cond ition Events Medical condition Events 
Allergic reaction (mild lo Mou1h ulcer 
11 9 
moderate) 
Ankle sprain/strain 11 Nasal congestion (space adaptation) 389 
Back injury 31 Neck injury 9 
Back pain (space adaptation) 382 Nose bleed (space adaptation) 6 
Barotrauma (ear/sinus block) 31 Otitis extema 3 
Choking/obstructed airway 3 Otitis media 3 
Constipation (space Paresthesias 
11 3 26 
adaptation) 
Diarmea 33 Pharyng itis 11 
Elbow sprain/strain 12 Respiratory infection 33 
Eye abrasion (foreign body) 70 Shoulder sprain/strain 22 
Eye chemical bum 6 Sinusitis 6 
Eye infection 5 Skin abrasion 94 
Finger dislocation 1 Skin infection 13 
Fingernail delamination (EVA) 16 Skin laceration 1 
Gastroenteritis 4 Skin rash 94 
Headache (CO2 induced) 20 Smoke inhalation 3 
Headache (late) 49 Space motion sickness (space adaptation) 325 
Headache (space adaptation) 233 Urinary incontinence (space adaptation) 5 
Hemormoids Urinary retention (space adaptation) -
2 5 
female 
Herpes Zoster reactivation 
1 
Urinary retention (space adaptation) - male 
4 (shingles) 
Indigestion 6 Urinary tract infection - female 5 
Influenza 1 Urinary tract infection - male 4 
Insomnia (space adaptation 
299 
Visual impairment/increased intracranial 
15 
pressure (space adaptation) 
Insomnia (late) 133 Wrist sprain/strain 5 
Knee sprain/strain 7 
How is medical care provided in mission?
• Live remote guidance
\
• Live monitoring
• Store and forward
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EXPLORATION SPACEFLIGHT
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NASA Human Spaceflight Missions
• Soyuz Launch and Landings
• International Space Station
• Commercial Crew Program
• Multi-Purpose Crew Vehicle
• Gateway Habitat
• Deep Space Transport
• Mars Missions
11
Near Term (Current - 5 yrs)
Medium Term (within 10 yrs)
Long Term (10 – 20 yrs)
Phase 1: Gateway
12
Orion
What about Mars?
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1. Radiation
2. Isolation and Confinement
3. Altered Gravity Fields
4. Hostile/closed environments
5. Distance from Earth
A Mars mission cannot use the current operational medical 
approach because that approach is dependent on 
evacuation for delivery of definitive care.
Mars
at start
Mars
at landing
Earth
at start
Earth at landing
Spacecraft
at landing
Spacecraft
at start
Trans-Mars Cruise
About 9 months
S. Love, E. Nelson, Mars Mission Concept of Operations, Aug 2016  
Access to  the Deep Space Network for the vehicle may 
be as limited as 1 hour in a 24 hour period.
A Mars mission cannot use the current operational medical 
approach because that approach is totally dependent 
on real-time communication with the ground. 
17
A Mars mission cannot use the current operational 
medical approach because that approach requires 
frequent resupply.
18
A Mars mission cannot use the current operational medical approach 
because that approach requires significant, continuous ground support.
Paradigm Shift
19
How do we scope a medical system to meet the needs of a 
planetary mission that is: 
2-3 times as long as any prior mission
>500 times as far as any prior mission
Vehicle is committed after trans-Martian injection?
MEDICAL PROBABILISTIC 
RISK ANALYSIS
20
Exploration Medical Conditions
SKIN
Burns secondary to Fire
Skin Abrasion
Skin Laceration
EYES
Acute Glaucoma
Eye Corneal Ulcer
Eye Infection
Retinal Detachment
Eye Abrasion
Eye Chemical Burn
Eye Penetration
EARS, NOSE, THROAT
Barotrauma (sinus block)
Nasal Congestion (SA)
Nosebleed (SA)
Acute Sinusitis
Hearing Loss
Otitis Externa
Otitis Media
Pharyngitis
DENTAL
Abscess
Caries
Exposed Pulp
Tooth Loss
Crown Loss
Filling Loss
CARDIOVASCULAR
Angina/Myocardial Infarction
Atrial Fibrillation / Atrial Flutter
Cardiogenic Shock secondary to 
Myocardial Infarction
Hypertension
Sudden Cardiac Arrest
Traumatic Hypovolemic Shock
GASTROINTESTINAL
Constipation (SA)
Abdominal Injury
Acute Cholecystitis
Acute Diverticulitis
Acute Pancreatitis
Appendicitis
Diarrhea
Gastroenteritis
Hemorrhoids
Indigestion
Small Bowel Obstruction
Pulmonary
Choking/Obstructed Airway
Respiratory Infection
Toxic Exposure:  Ammonia
Smoke Inhalation
Chest Injury
*SA – Space Adaptation
NEUROLOGIC
Space Motion Sickness (SA)
Head Injury
Seizures
Headache
Stroke
Paresthesia
Headache (SA)
Neurogenic Shock
VIIP (SA)
MUSKULOSKELETAL
Back Pain (SA)
Abdominal Wall Hernia
Acute Arthritis
Back Injury
Ankle Sprain/Strain
Elbow Dislocation
Elbow Sprain/Strain
Finger Dislocation
Fingernail Delamination (EVA)
Hip Sprain/Strain
Hip/Proximal Femur Fracture
Knee Sprain/Strain
Lower Extremity Stress fracture
Lumbar Spine Fracture
Shoulder Dislocation
Shoulder Sprain/Strain
Acute Compartment Syndrome
Neck Injury
Wrist Sprain/Strain
Wrist Fracture
PSYCHIATRIC
Insomnia (Space Adaptation)
Late Insomnia
Anxiety
Behavioral Emergency
Depression
GENITOURINARY
Abnormal Uterine Bleeding
Acute Prostatitis
Nephrolithiasis
Urinary Incontinence (SA)
Urinary Retention (SA)
Vaginal Yeast Infection
INFECTION
Herpes Zoster (shingles)
Influenza
Mouth Ulcer
Sepsis
Skin Infection
Urinary Tract Infection
IMMUNE
Allergic Reaction
Anaphylaxis
Skin Rash
Medication Reaction
ENVIRONMENT
Acute Radiation Syndrome
Altitude Sickness
Decompression Sickness (EVA)
Headache (CO2) 21
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~100 Medical Conditions
Medical Conditions for which we have not planned.
Spaceflight Medical Risk
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How do we extrapolate human system risk?
• Lack of single source for data
• Flight data- high internal validity, small volume
• Analog data- Lower validity, higher volume
• Expert opinion
Extrapolating Medical Risk
IMM Framework: Event Simulation
Best-case 
resources 
available?
Worst-case 
resources 
available?
Treated Case: 
Decrement medical 
resources
Untreated Case 
Decrement medical 
resources
Treated case: 
Decrement medical 
resources
Untreated        
Worst-Case 
Decrement medical 
resources
Calculate End States:
• Evacuation 
(EVAC)
• Loss of Crew Life 
(LOCL)
• Crew Health 
Index (CHI)
• Resource 
Utilization
• Type and Number 
of Medical Events
Best-case Scenario
Worst-case Scenario
Yes
Yes
No
No
Medical Event
Slide courtesy of E Kerstman
Probabilistic Risk Assessment
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Proportion of Mission Risk attributable to Medical
Launch 
J 
730 Mars Transit 
365 Deep Space Transport 
128 Shuttle/lSS 
42 Gateway 
21 EM2 
14 Space Shuttle 
Mission Risk (LOG) 
Some IMM Assumptions…
1. All diagnoses are 100% accurate.
2. All events receive appropriate treatment.
3. All meds and equipment are 100% reliable and effective.
4. All events respond as they would terrestrially.
5. No mistakes in medical procedures (regardless of training)
6. Power, water, oxygen unlimited
0.00
0.01
0.02
0.03
0.04
0.05
0.06
0.07
21 Day Lunar 6 Month ISS 1 Year ISS 2.5 Years Mars
Perfect
Physician - No Detraining
Non-Physician - No
Detraining
Design Reference Mission
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Slide courtesy of E Kerstman
PRA Estimates of Loss of Crew Life
• 
...J 
0 • 
0 
...J Q. • 
Proportion of Mission Risk attributable to Medical
Launch 
J 
730 Mars Transit 
365 Deep Space Transport 
128 Shuttle/lSS 
42 Gateway 
21 EM2 
14 Space Shuttle 
Mission Risk (LOG) 
“…[The] assumption has been that
risk of vehicle system
malfunction far outweighs the
risk of human system
failure…NASA buys down the risk
of failure of the human system
through rigorous selection of
individuals designed to minimize
medical issues and optimize
available capability in flight.”
NASA SP-2017-0633
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ENGINEERING, LIFE SCIENCES, 
AND HEALTH/MEDICINE SYNERGY 
IN AEROSPACE HUMAN SYSTEMS INTEGRATION 
THE ROSETTA STONE PROJECT 
Ed1t0d by Richard S. Williams and Charles R. Doarn 
CREW HEALTH AND 
PERFORMANCE SYSTEM
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Habitat System
Ground System
Crew as 
Physician 
Crew as 
Explorer 
or Patient 
Structures
Command 
& Data 
Handling
Guidance, 
Navigation 
and Control
Comm & 
Tracking
Power etc.
Crew Health and Performance
Medical
J. Mindock
Natural 
and Induced 
Environments 
Protection Mission Task 
Performance
Health
and Wellness
Vehicle/Mission Architecture Integration
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• Protect from environmental hazards
– Radiation protection
– Noise, vibration, CO2, etc.
• Keep healthy crew well
– Exercise
– Other physiological countermeasures
– Food
– Behavioral health
• Prevent, diagnose, treat, manage long-term health care
– Data system
• Medical Data Capture
• Medical Training
– Medical devices
– Medical supplies
• Support crew to accomplish mission tasks 
– Procedures
– Training
– User interfaces
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Crew Health and Performance System Must…
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System Performance Threatened by Sleep Deficit
Biomonitoring 
Emergency response / 
Medical Equipment 
Medical Skills Maintenance 
Pharmacy 
Food and Nutrition 
Waste Management 
Radiation Monitoring 
Air Quality 
Cognition 
Water Quality 
Team Cohesion 
Team Dynamics 
Training Capabilities 
Mood 
Physical Strength 
/E . E . / xerc1se qu1pment 
CO2 Levels 
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Sleep Deficit Affects Other System Aspects
Ground Support 
Biomonitoring ~ 
Emergency response 
Medical Equipment 
Medical Skills Maintenance 
Pharmacy 
Food and Nutrition 
Waste Management 
Radiation Monitoring 
Air Quality 
Cognition 
Water Quality 
~ ,----------, 
I Team Cohesion I 
I Team Dynamics I 
Physical Strength 
/ Exercise Equipment 
CO2 Levels 
Translate Medicine to Engineering
Subsystem 
requirements & 
architecture
Do we have the capabilities to 
meet the needs?
What allocations are 
necessary?
System 
requirements 
& architecture
Stakeholder 
needs, goals
NASA 
Standards
Program 
requirements 
& 
architecture
Characterize 
system
Analyze 
& trade
Design 
& Build
	
System 
functions & 
behaviors
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context
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HEOMD
ESD
DSG DST
PPE Hab Logistics Airlock
Devices Supplies
Structures Power Etc
Lev 0
Lev 1
Lev 2
Lev 3
Lev 4
The habitat 
medical system 
shall…
Ground 
System
HRP
Ground 
Medical
Health & 
Wellness
Etc
Crew Health
& Perf
Crew Health
& Perf
Data 
System
The ground medical 
system shall…
The DSG 
shall…
The DSG 
habitat shall…
The CH&P 
system shall…
Ground 
Ops Sys?
Lev 5 The XYZ 
device  shall…
Habitat
Medical
TRADE SPACE ANALYSIS
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Medical and Non-medical Risk
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Mass/Volume of Medical System
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Total Risk
0
Ideal Mission Risk
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Medical Systems Engineering
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From “System Engineering at JPL” training course material, June 1991.
Crew Health 
and 
Performance 
System
.JPL 
06/14/91 4.9 
MEDICAL DATA ARCHITECTURE
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Behavioral MedicalPharmacy
Performance Nutrition Sleep
Environment
Phone Home
Training CMO Only
Crew Health and Performance System
Notional
Laboratory
Diagnosis
Equipment Imaging
Procedures
EMR Dashboard
Inventory
References
These technologies exist today
Medical
We’re not bringing an Intensive Care Unit but…
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• 
Where are we today? MDA
Data Sources 
Layer
Data Storage 
Layer
Analytical Layer User InterfaceDiscovery & 
Analytics
Structured
Unstructured
Streams
Health Records
Med Records
Clinical Trials
Other ….
Medical devices
Monitoring 
System 
Images
Logs & Notes
Exercise 
Machine
Bio Sensors
Env. Sensors
Other ….
Other ….
H
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EHR Documents
Sensor Other
Vitals
Data Assets
Data Models
Annotate
Correlate
Classify
Integrated Data 
Platform
Clinical 
Decision 
Support
System 
D
at
a 
S
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s
Analytics 
Data Mart
Relational 
Data Mart
non 
relational 
Reports
Dashboard
Data Mining
Text Classification
Computational 
Statistics
Modeling & 
Analytics
Diagnostic
Predictive
Discovery
Ontological Search
Real Time Apps
Alerts
Cognitive 
Computing
Adaptive, Interactive, 
Contextual
A
P
I,
 I
n
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 S
e
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s
Applications
& 
Prototypes
User
Interface & 
Visualization
Metadata & Data Standards
Data Virtualization
Federated Access & Delivery Infrastructure (FADI) 
Knowledge 
Base
Knowledge 
Models
-
Databases Data Warcrouse Dependenl Data Marts 
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Areostationar Satellite 
Mission: Primary - Comm Relay; secondary - Science/Explor,l.tion 
Continuous relay availability for surface assets -' 
High availability for low-altitude orbiters and CubeSats 
High-performance directional prox1m1ty lmks 
Hii:h -performance Earth link 
Low-Altitude Science Orbiter 
Mission: Prime - Science/Exploration; secondary - Comm Rela 
• High-performance Earth link for science data return 
• Intermittent relay services 1-20 min/sol to Surface Asset) 
.,. 
• Low-rate command and telemetry on Earth link 
• Continuously available high-rate relay link via 
Areostationary Relay Satellite 
• Intermittent high-rate relay to science orbiter(s) 
Communication Technolo ies 
• New! Deep space optical communications: smaller, llghter, 
lower power flight terminals combined with large aperture 
ground telescopes offer 10-l00x higher data rates 
Advanced deep ,pace RF communications: higher power and 
frequency, larger aperture, and sophisticated processing offer 
10-20x higher data rates 
Figure 1. Advanced RF and optical communications technolog ies combined with using the areostationary 
orbit offer 100-1000x greater data return from Mars and nearly continuous avai labil ity. 
Table 1. High-Performance Mars-Earth Trunk Line Capabil ity 
I Frequency I Maturity I 5/C I 5/C Txmt I Ground Receiver I Data Rate Band Aperture Power (@2 AU) 
Current Operational 3m 100W 34 m DSN BWG 1 Mb/s 
State-of-the- X-band antenna 
Art (MRO) 
TRL 6 3m 200 W 34 m DSN BWG 5 Mb/s 
Ka-band antenna 
TRL 3-4 5m 1 kW 34 m DSN BWG 70 Mb/s 
Next- antenna 
Generation TRL 6 (DSOC; to fly 22 cm 4W 5 m ground 1 Mb/s 
Trunk Line on 2023 Psyche telescope Options Optical Discovery Mission (1 550 nm) 
TRL 3 50 cm 50W 12 m ground 100 Mb/s 
telescope 
Can we replace the doctor?
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Crawl
Walk
Run
Fly• Full Artificial Intelligence
• Integrative Health and Performance Prediction
• Condition Specific Guidance
• Differential Diagnosis Generation
• Automated Image/Data Analysis
• Knowledge Support/Known Algorithm Provision
• Preventive Care Strategies
Autonomy - COMfORT
Fundoscopy – Retinal Imaging
Intubation Emergency
Urinary Tract – Kidney and Bladder 
Ultrasound Imaging
Ultrasound 
Guided 
IV Insertion
Diagnosis and Treatment Exercise
Abdomen 
-.IO.lrll!,llbffit.st<¥e~lll!US<!lefldemeuiofl'lll)ati01'1. 
<IS.~guattq 
Perform physical exam, and collect vitals. 
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Fundoscopy
Fundoscopy Module
COMfORT-§fff±f--- ~ ~~~~ ----- EXIT 
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TAKING A Gooo IMAGE: COMPOSITION 
T ips fo r good compos it io n: 
To move the optic disc dawn the 
subject needs to look up. 
To move the optic disc right the 
subject needs to look right. 
In a good composition the optic 
disc is centered. 
Goad composit ion 
Toking Im ages Eye =>a hology,,__ ________________ ~-
Bad composit ion 
In poor composit ion, the optic disc is not centered or not visible. 
Bad composition 
Optic disc is too far right 
Bad composit ion 
Optic disc is too low 
Medical Technology Development
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SEEQ Mobile Cardiac Telemetry System: Medtronic
FUS moving stone in ER patient.
Reveal LINQ ICM 
PHARMACY
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Stability Evidence: Flown Studies
Altered 
Medication
Unaltered 
Medication
Du et al. 2011
Chuong et al. 2011
Wotring 2016
Unpublished:
Cory 2017
Wu 2016
* Drug tested only for Vit B API
** Drug would fail by today’s API standard
† drug had unidentified degradant product
- - J Ground Control Available 
I 
Acyclovir Lidocaine 
Amoxicillin/Clavula nate Metoprolol 
Atorvastatin Metronidazole 
Azithromycin Mupirocin 
Cefadroxil Nasal Cobolamine 
Ciprofloxacin Phenytoin 
Clotrimazole Progestin/Estrogen 
Dextroamphetamine Promethazine 
Epinephrine Rised ro nate 
Fluconazole Sertraline 
Furosemide Silver Sulfadiazine 
Ibuprofen Sulfamethoxazole/ 
lmipenem/Cilastin Trimethoprim 
Levofloxacin Temazepam 
Levothyroxine Triamcinolone 
• 
• 
• 
• 
···· • • • 
n 
API and Physical Characteristics 
API (B Vitamin only) 
I I Centrum Silver4> Multivitamin• I API 
Women's Once-A-Daf' Multivitamin* Physic 
, Degradants, 
al Characteristics 
I 
Aspirin 
Acetaminophen"' 
Ibuprofen 
Loratadine** t 
Loperamide t 
Pseudoephedrine 
Melatonin 
Modafinilt 
Zolp1demt 
Unpublished Unpublished 
Results Results 
Ibuprofen 
Levofloxacin 
Phenytoin 
Sertraline 
Valacyclovir 
-
Ibuprofen 
Promethazine 
Azithromycin 
• 
• 
Other Topics within In-Flight Medical Conditions
• Imaging
• Rehabilitation
• Lab Analysis
• Biomonitoring and Wearables
• Personalized Medicine
• Renal Stones
50
Safe Passage
• From Conclusion 6: 
• “The human being 
must be integrated 
into the space 
mission in the same 
way in which all other 
aspects of the 
mission are 
integrated.” 
Committee on Creating a Vision for Space Medicine During Travel Beyond Earth 
Orbit, Board on Health Sciences Policy and I. O. Medicine, Safe Passage: 
Astronaut Care for Exploration Missions, Institute of Medicine of the National 
Academies Press, 2001. 
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Rosetta Stone
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Questions?
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